News – Page 111 – Endpoints News

Investors pour $370M+ into Ken Song's autoimmune biotech after his RayzeBio success

9 months ago

Merck, Daiichi Sankyo detail Phase 2 ADC results in small cell lung cancer, bispecific combo strategy

9 months ago

Lilly again hires from within for CFO post, elevating 23-year company veteran

9 months ago

MBX seeks $114M IPO to compete with Ascendis and get a long-acting GLP-1/GIP prodrug into the clinic

9 months ago

Relay Therapeutics reports positive PFS data for its PI3Kα inhibitor combo in breast cancer

9 months ago

Terns’ oral GLP-1 passes Phase 1 test with promising weight loss after one month

9 months ago

Eli Lilly invests in Superluminal's $120M Series A round as AI-focused startups eye the clinic

9 months ago

Summit's Phase 3 data back up biotech's boasts of beating Keytruda in lung cancer

9 months ago

Notable shakeups this week; Recursion's mixed data; Eli Lilly's $1B bet; and more

9 months ago

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

9 months ago

Federal judge rejects pharma industry’s request to halt Maryland’s 340B law

9 months ago

Non-viral delivery startup Vesigen Therapeutics trims staff as it evaluates 'strategic options'

9 months ago

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

9 months ago

FDA grants full approval to Travere’s Filspari for IgAN

9 months ago

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

9 months ago

Milestone’s arrhythmia drug on track for China filing with new Phase 3 data

9 months ago

Basilea records $25M milestone; Connect Biopharma reduces workforce in China

9 months ago

Bicara, Zenas outline plans for $180M IPOs amid restored optimism for biotech debuts

9 months ago

GSK’s Nucala cuts exacerbations in Phase 3 COPD trial, but numbers remain under wraps

9 months ago

Roche's Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed

9 months ago

Exclusive: Lilly-backed OrsoBio raises $67M for slate of obesity drugs as combinations take root

9 months ago

FDA raises antimicrobial resistance concerns ahead of adcomm for Iterum's UTI treatment

9 months ago

CBER chief forecasts better global regulatory convergence around cell and gene therapies

9 months ago

J&J increases talc settlement by $1.1B after negotiating with plaintiffs, lawyers say

9 months ago

First page Previous page 108 109 110111112 113 114 Next page Last page